peptide-research
Why Different Peptide Salts and Forms May Be Ev...
Different peptide salts and molecular forms may be evaluated separately because they are not always analytically, physically, or pharmaceutically identical. A free-base peptide, acetate salt, another counterion form, fragment, analog,...
Why Different Peptide Salts and Forms May Be Ev...
Different peptide salts and molecular forms may be evaluated separately because they are not always analytically, physically, or pharmaceutically identical. A free-base peptide, acetate salt, another counterion form, fragment, analog,...
Why Formulation-Specific Evidence Matters
Formulation-specific evidence matters because a finished peptide product is more than its active ingredient. Excipients, strength, dosage form, manufacturing process, release behavior, stability, packaging, storage, and route of administration can...
Why Formulation-Specific Evidence Matters
Formulation-specific evidence matters because a finished peptide product is more than its active ingredient. Excipients, strength, dosage form, manufacturing process, release behavior, stability, packaging, storage, and route of administration can...
How Product Quality Can Affect Safety Conclusions
Product quality can affect safety conclusions because an adverse event may result from the intended peptide, an impurity, contamination, incorrect strength, degradation, aggregation, a formulation component, or a manufacturing failure....
How Product Quality Can Affect Safety Conclusions
Product quality can affect safety conclusions because an adverse event may result from the intended peptide, an impurity, contamination, incorrect strength, degradation, aggregation, a formulation component, or a manufacturing failure....
How Identity and Purity Affect Peptide Evaluation
Identity and purity affect peptide evaluation because researchers and regulators must know what material was tested before they can interpret biological activity, human exposure, safety findings, or product performance. Identity...
How Identity and Purity Affect Peptide Evaluation
Identity and purity affect peptide evaluation because researchers and regulators must know what material was tested before they can interpret biological activity, human exposure, safety findings, or product performance. Identity...
What Safety Signals Do Regulators Look For?
Regulators look for safety signals that suggest a possible new risk, a change in a known risk, an unexpected pattern of adverse events, a product-quality problem, or a relationship between...
What Safety Signals Do Regulators Look For?
Regulators look for safety signals that suggest a possible new risk, a change in a known risk, an unexpected pattern of adverse events, a product-quality problem, or a relationship between...
How to Read an FDA Briefing Document
To read an FDA briefing document accurately, begin by identifying the meeting, regulatory question, document author, substance or product under review, proposed use, route, and stage of the process. Then...
How to Read an FDA Briefing Document
To read an FDA briefing document accurately, begin by identifying the meeting, regulatory question, document author, substance or product under review, proposed use, route, and stage of the process. Then...